Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Nyman

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2025
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II TrialBjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN studyBjörn Zackrisson, Per Nilsson, Elisabeth Kjellén, et al.
The Lancet. Oncology|December 17, 2013
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trialCharles Butts, Mark A Socinski, Paul L Mitchell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2008
The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRTKarl-Axel Johansson, Per Nilsson, Björn Zackrisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2021
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body RadiotherapyKarin Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Acta Oncologica (Stockholm, Sweden)|August 9, 2019
Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration groupMarkus Stock, Joanna Gora, Ana Perpar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2026
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS CohortKristin Karlsson, Tiziana Rancati, Elias Lindbäck, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2023
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung TumorsSara Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
Noninvasive detection of any-stage cancer using free glycosaminoglycansSinisa Bratulic, Angelo Limeta, Saeed Dabestani, et al.
Lung Cancer (Amsterdam, Netherlands)|April 4, 2025
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS studySara Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2025
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II TrialBjørn Henning Grønberg, Kristin Toftaker Killingberg, Øystein Fløtten, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 8, 2011
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN studyBjörn Zackrisson, Per Nilsson, Elisabeth Kjellén, et al.
The Lancet. Oncology|December 17, 2013
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trialCharles Butts, Mark A Socinski, Paul L Mitchell, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 22, 2008
The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRTKarl-Axel Johansson, Per Nilsson, Björn Zackrisson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2021
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body RadiotherapyKarin Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Acta Oncologica (Stockholm, Sweden)|August 9, 2019
Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration groupMarkus Stock, Joanna Gora, Ana Perpar, et al.
International Journal of Radiation Oncology, Biology, Physics|January 14, 2026
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS CohortKristin Karlsson, Tiziana Rancati, Elias Lindbäck, et al.
International Journal of Radiation Oncology, Biology, Physics|July 9, 2023
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung TumorsSara Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2022
Noninvasive detection of any-stage cancer using free glycosaminoglycansSinisa Bratulic, Angelo Limeta, Saeed Dabestani, et al.
Lung Cancer (Amsterdam, Netherlands)|April 4, 2025
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS studySara Lindberg, Vitali Grozman, Kristin Karlsson, et al.
Pageof 7